Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Harald Seifert

Showing results (11-20 of 239) with videos related to

Pageof 24
Sort By:
The Journal of Antimicrobial Chemotherapy|August 13, 2013
Insertion sequence IS18 mediates overexpression of blaOXA-257 in a carbapenem-resistant Acinetobacter bereziniae isolateEsther Zander, Harald Seifert, Paul G Higgins
International Journal of Antimicrobial Agents|July 15, 2017
In-vitro activity of ceftolozane/tazobactam against Pseudomonas aeruginosa and Enterobacteriaceae isolates recovered from hospitalized patients in GermanyHarald Seifert, Barbara Körber-Irrgang, Michael Kresken, et al.
Antimicrobial Agents and Chemotherapy|March 23, 2016
Effects of Saline, an Ambient Acidic Environment, and Sodium Salicylate on OXA-Mediated Carbapenem Resistance in Acinetobacter baumanniiEsther Zander, Harald Seifert, Paul G Higgins
International Journal of Antimicrobial Agents|July 18, 2018
In vitro activity of tigecycline and comparators (2014-2016) among key WHO 'priority pathogens' and longitudinal assessment (2004-2016) of antimicrobial resistance: a report from the T.E.S.T. studyHarald Seifert, Joseph Blondeau, Michael J Dowzicky
IUBMB Life|October 19, 2011
Acinetobacter infection--an emerging threat to human healthPaolo Visca, Harald Seifert, Kevin J Towner
Future Microbiology|May 26, 2018
Oritavancin: an updateGreta Flüh, Harald Seifert, Achim J Kaasch
Diagnostic Microbiology and Infectious Disease|March 27, 2010
Activity of doripenem with and without levofloxacin, amikacin, and colistin against Pseudomonas aeruginosa and Acinetobacter baumanniiGlenn A Pankuch, Harald Seifert, Peter C Appelbaum
Journal of Clinical Microbiology|July 29, 2011
Evaluation of quantitative antibiotic susceptibility testing by Vitek 2 as a routine method to predict strain relatedness of coagulase-negative staphylococci isolated from blood culturesAntonia Camerer, Anke Kohlenberg, Danuta Stefanik, et al.
International Journal of Antimicrobial Agents|June 12, 2020
In vitro activity of ceftazidime-avibactam against Gram-negative isolates collected in 18 European countries, 2015-2017Gregory G Stone, Harald Seifert, Carl Erik Nord
Clinical Microbiology Reviews|July 16, 2008
Acinetobacter baumannii: emergence of a successful pathogenAnton Y Peleg, Harald Seifert, David L Paterson
Pageof 24

Showing results (11-20 of 239) with videos related to

Sort By:
Pageof 24
The Journal of Antimicrobial Chemotherapy|August 13, 2013
Insertion sequence IS18 mediates overexpression of blaOXA-257 in a carbapenem-resistant Acinetobacter bereziniae isolateEsther Zander, Harald Seifert, Paul G Higgins
International Journal of Antimicrobial Agents|July 15, 2017
In-vitro activity of ceftolozane/tazobactam against Pseudomonas aeruginosa and Enterobacteriaceae isolates recovered from hospitalized patients in GermanyHarald Seifert, Barbara Körber-Irrgang, Michael Kresken, et al.
Antimicrobial Agents and Chemotherapy|March 23, 2016
Effects of Saline, an Ambient Acidic Environment, and Sodium Salicylate on OXA-Mediated Carbapenem Resistance in Acinetobacter baumanniiEsther Zander, Harald Seifert, Paul G Higgins
International Journal of Antimicrobial Agents|July 18, 2018
In vitro activity of tigecycline and comparators (2014-2016) among key WHO 'priority pathogens' and longitudinal assessment (2004-2016) of antimicrobial resistance: a report from the T.E.S.T. studyHarald Seifert, Joseph Blondeau, Michael J Dowzicky
IUBMB Life|October 19, 2011
Acinetobacter infection--an emerging threat to human healthPaolo Visca, Harald Seifert, Kevin J Towner
Future Microbiology|May 26, 2018
Oritavancin: an updateGreta Flüh, Harald Seifert, Achim J Kaasch
Diagnostic Microbiology and Infectious Disease|March 27, 2010
Activity of doripenem with and without levofloxacin, amikacin, and colistin against Pseudomonas aeruginosa and Acinetobacter baumanniiGlenn A Pankuch, Harald Seifert, Peter C Appelbaum
Journal of Clinical Microbiology|July 29, 2011
Evaluation of quantitative antibiotic susceptibility testing by Vitek 2 as a routine method to predict strain relatedness of coagulase-negative staphylococci isolated from blood culturesAntonia Camerer, Anke Kohlenberg, Danuta Stefanik, et al.
International Journal of Antimicrobial Agents|June 12, 2020
In vitro activity of ceftazidime-avibactam against Gram-negative isolates collected in 18 European countries, 2015-2017Gregory G Stone, Harald Seifert, Carl Erik Nord
Clinical Microbiology Reviews|July 16, 2008
Acinetobacter baumannii: emergence of a successful pathogenAnton Y Peleg, Harald Seifert, David L Paterson
Pageof 24